These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31189329)

  • 21. Gadoxetic acid-enhanced magnetic resonance imaging significantly influences the clinical course in patients with colorectal liver metastases.
    Sibinga Mulder BG; Visser K; Feshtali S; Vahrmeijer AL; Swijnenburg RJ; Hartgrink HH; van den Boom R; Burgmans MC; Mieog JSD
    BMC Med Imaging; 2018 Nov; 18(1):44. PubMed ID: 30442100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The added diagnostic value of complementary gadoxetic acid-enhanced MRI to
    Puhr-Westerheide D; Cyran CC; Sargsyan-Bergmann J; Todica A; Gildehaus FJ; Kunz WG; Stahl R; Spitzweg C; Ricke J; Kazmierczak PM
    Cancer Imaging; 2019 Nov; 19(1):73. PubMed ID: 31727170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.
    Charnsangavej C; Clary B; Fong Y; Grothey A; Pawlik TM; Choti MA
    Ann Surg Oncol; 2006 Oct; 13(10):1261-8. PubMed ID: 16947009
    [No Abstract]   [Full Text] [Related]  

  • 24. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
    Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ
    Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is MRI of the Liver Needed During Routine Preoperative Workup for Colorectal Cancer?
    Kang SI; Kim DW; Cho JY; Park J; Lee KH; Son IT; Oh HK; Kang SB
    Dis Colon Rectum; 2017 Sep; 60(9):936-944. PubMed ID: 28796732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging.
    Min JH; Kim YK; Choi SY; Kang TW; Jeong WK; Kim K; Won HJ
    Br J Radiol; 2018 Oct; 91(1090):20180177. PubMed ID: 29927634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis.
    Choi SH; Kim SY; Park SH; Kim KW; Lee JY; Lee SS; Lee MG
    J Magn Reson Imaging; 2018 May; 47(5):1237-1250. PubMed ID: 28901685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging.
    Lee DH; Lee JM; Hur BY; Joo I; Yi NJ; Suh KS; Kang KW; Han JK
    Radiology; 2016 Sep; 280(3):782-92. PubMed ID: 27092659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a "defect" on the hepatobiliary phase.
    Kim A; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
    Eur J Radiol; 2012 Dec; 81(12):3998-4004. PubMed ID: 22921889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additional value of gadoxetic acid-enhanced MRI to conventional extracellular gadolinium-enhanced MRI for the surgical management of colorectal and neuroendocrine liver metastases.
    Morin C; Drolet S; Daigle C; Deshaies I; Ouellet JF; Ball CG; Dixon E; Marceau J; Ouellet JB
    HPB (Oxford); 2020 May; 22(5):710-715. PubMed ID: 31640929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and Viability of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Multiparametric PET/CT-MRI Study.
    Dunet V; Halkic N; Prior JO; Anaye A; Meuli RA; Sempoux C; Denys A; Schmidt S
    Clin Nucl Med; 2017 Apr; 42(4):258-263. PubMed ID: 28166142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.
    Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kikuchi Y; Otsuka Y; Kaneko H; Igarashi Y; Sumino Y
    J Clin Ultrasound; 2017 Mar; 45(3):138-144. PubMed ID: 27861987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the Gadoxetic Acid-Enhanced Liver MRI Impact on the Treatment of Patients with Colorectal Cancer? Comparison Study with ¹⁸F-FDG PET/CT.
    Oh JW; Oh SN; Choi JI; Choi MH; Yoo IeR; Lee MA; Yoo YK; Oh ST
    Biomed Res Int; 2016; 2016():8412071. PubMed ID: 27022613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
    Dupré A; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2017 Oct; 43(10):1901-1907. PubMed ID: 28888801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of imaging for patients with colorectal hepatic metastases: what the radiologist needs to know.
    Reiter MJ; Hannemann NP; Schwope RB; Lisanti CJ; Learn PA
    Abdom Imaging; 2015 Oct; 40(8):3029-42. PubMed ID: 26194812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI in addition to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international, multicentre, prospective, diagnostic accuracy trial.
    Görgec B; Hansen IS; Kemmerich G; Syversveen T; Abu Hilal M; Belt EJT; Bosscha K; Burgmans MC; Cappendijk VC; D'Hondt M; Edwin B; van Erkel AR; Gielkens HAJ; Grünhagen DJ; Gobardhan PD; Hartgrink HH; Horsthuis K; Klompenhouwer EG; Kok NFM; Kint PAM; Kuhlmann K; Leclercq WKG; Lips DJ; Lutin B; Maas M; Marsman HA; Meijerink M; Meyer Y; Morone M; Peringa J; Sijberden JP; van Delden OM; van den Bergh JE; Vanhooymissen IJS; Vermaas M; Willemssen FEJA; Dijkgraaf MGW; Bossuyt PM; Swijnenburg RJ; Fretland ÅA; Verhoef C; Besselink MG; Stoker J;
    Lancet Oncol; 2024 Jan; 25(1):137-146. PubMed ID: 38081200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease.
    Denecke T; Steffen I; Hildebrandt B; Rühl R; Streitparth F; Lehmkuhl L; Langrehr J; Ricke J; Amthauer H; Hänninen EL
    Acta Radiol; 2007 Oct; 48(8):821-30. PubMed ID: 17924212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
    J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.